Literature DB >> 34998045

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.

Michael Curtis1, Justin Berk2, Sarah Larney3, Josiah D Rich4, Mark Stoové5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34998045      PMCID： PMC8810681          DOI： 10.1016/j.drugpo.2021.103572

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  20 in total

1.  A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.

Authors:  Sarah Larney; Deborah Zador; Natasha Sindicich; Kate Dolan
Journal:  Drug Alcohol Rev       Date:  2016-06-21

2.  Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers.

Authors:  Sandra M Bucerius; Kevin D Haggerty
Journal:  Int J Drug Policy       Date:  2019-07-23

3.  Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.

Authors:  Sarah Larney; Barbara Toson; Lucy Burns; Kate Dolan
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

4.  Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.

Authors:  John Marsden; Garry Stillwell; Hayley Jones; Alisha Cooper; Brian Eastwood; Michael Farrell; Tim Lowden; Nino Maddalena; Chris Metcalfe; Jenny Shaw; Matthew Hickman
Journal:  Addiction       Date:  2017-03-01       Impact factor: 6.526

5.  Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice.

Authors:  Michelle McKenzie; Amy Nunn; Nickolas D Zaller; Alexander R Bazazi; Josiah D Rich
Journal:  J Opioid Manag       Date:  2009 Jul-Aug

Review 6.  Public health alternatives to incarceration for drug offenders.

Authors:  Nicholas Clark; Kate Dolan; David Farabee
Journal:  East Mediterr Health J       Date:  2017-05-01       Impact factor: 1.628

7.  Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.

Authors:  Nicholas Lintzeris; Adrian J Dunlop; Paul S Haber; Dan I Lubman; Robert Graham; Sarah Hutchinson; Shalini Arunogiri; Victoria Hayes; Peter Hjelmström; Agneta Svedberg; Stefan Peterson; Fredrik Tiberg
Journal:  JAMA Netw Open       Date:  2021-05-03

8.  Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Authors:  Traci C Green; Jennifer Clarke; Lauren Brinkley-Rubinstein; Brandon D L Marshall; Nicole Alexander-Scott; Rebecca Boss; Josiah D Rich
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 25.911

9.  Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?

Authors:  Robert G Carlson; Raminta Daniulaityte; Sydney M Silverstein; Ramzi W Nahhas; Silvia S Martins
Journal:  Int J Drug Policy       Date:  2020-04-17

10.  Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's Cases.

Authors:  Emily Groot; Fiona G Kouyoumdjian; Lori Kiefer; Parvaz Madadi; Jeremy Gross; Brittany Prevost; Reuven Jhirad; Dirk Huyer; Victoria Snowdon; Navindra Persaud
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.